AHA 2019: DAPA-HF - Dr Harriette Van Spall & Prof John McMurray


Dr Harriette Van Spall (McMaster University, Ontario, CA) & Prof John McMurray (Glasgow University Hospital, UK) discuss the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) - Sub-studies and sensitivity analyses.


Filmed on site at AHA 2019 by Radcliffe Cardiology.

Videographer: Tom Green & Dominic Woodruff